Apolipoprotein B mRNA-editing, catalytic polypeptide cytidine deaminases and retroviral restriction

Wiley Interdisciplinary Reviews: RNA

Volumn 3, Issue 4, 2012, Pages 529-541

  Koito, Atsushi ^a   Ikeda, Terumasa ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3A; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3B; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3C; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3F; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; CYTIDINE DEAMINASE; GENOMIC DNA; GENOMIC RNA; TRANSFER RNA; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; CATALYSIS; CHROMOSOME 22; CYTOPLASM; DEAMINATION; DNA REPLICATION; DNA SYNTHESIS; DNA TRANSPOSITION; DRUG MECHANISM; ENDOGENOUS RETROVIRUS; GENE; GENE DISRUPTION; GENE DOSAGE; GENE INSERTION; GENE REPLICATION; GENETIC VARIABILITY; GENOME; HAPLOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNITY; LIPID TRANSPORT; LONG TERMINAL REPEAT; MURINE LEUKEMIA VIRUS; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; PROTEIN DOMAIN; RETROPOSON; RETROVIRUS; REVIEW; ROUS SARCOMA ONCOVIRUS; VIRUS INHIBITION; VIRUS PATHOGENESIS;

ANIMALS; CYTIDINE DEAMINASE; HUMANS; RETROELEMENTS; RETROVIRIDAE;

EID: 84867599386     PISSN: 17577004     EISSN: 17577012     Source Type: Journal    
DOI: 10.1002/wrna.1117     Document Type: Review

References (83)

1. Sheehy AM, Gaddis NC, Choi JD, Malim MH. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 2002, 418:646-650.
2. Holmea RK, Malim MH, Bishop KN. APOBEC-mediated viral restriction: not simply editing? Trends Biochem Sci 2007, 32:118-128.
3. Chiu Y-L, Green WC. The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements. Annu Rev Immunol 2007, 26:317-353.
4. Beauregard A, Curcio MJ, Belfort M. The take and give between retrotransposable elements and their hosts. Annu Rev Genet 2008, 42:587-617.
5. Wedekind JE, Dance GSC, Sowden MP, Smith HC. Messenger RNA editing in mammals: new members of the APOBEC family seeking roles in the family business. Trends Genet 2003, 19:207-216.
6. Liao W, Hong SH, Chan BH, Rudolph FB, Clark SC, Chan L. APOBEC-2, a cardiac- and skeletal muscle-specific member of the cytidine deaminase supergene family. Biochem Biophys Res Commun 1999, 260:398-404.
7. Rogozin IB, Basu MK, Jordan IK, Pavlov YI, Koonin EV. APOBEC4, a new member of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases predicted by computational analysis. Cell Cycle 2005, 4:1281-1285.
8. Jarmuz A, Chester A, Bayliss J, Gisbourne J, Dunham I, Scott J, Navaratnam N. An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics 2002, 79:285-296.
9. Cullen BR. Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors. J Virol 2006, 80:1067-1076.
10. LaRue RS, Jónsson SR, Silverstein KAT, Lajoie M, Bertrand D, El-Mabrouk N, Hötzel I, Andrésdóttir V, Smith TPL, Harris RS. The artiodactyls APOBEC3 innate immune repertoire shows evidence for a multi-functional domain organization that existed in the ancestor of placental mammals. BMC Mol Biol 2008, 9:104.
11. LaRue RS, Andrésdóttir V, Blanchard Y, Conticello SG, Derse D, Emerman M, Green WC, Jónsson SR, Landau NR, Löchelt M, et al. Guigelines for naming nonprimate APOBEC3 genes and proteins. J Virol 2009, 83:494-497.
12. Smith HC. APOBEC3G: a double agent in defense. Trends Biochem Sci 2011, 36:239-244.
13. Smith HC, Bennett RP, Kizilyer A, McDougall WM, Prohaska KM. Functions and regulation of the APOBEC family of proteins. Semin Cell Dev Biol 2012. In press.
14. Lecossier D, Bouchonnet F, Clavel F, Hance AJ. Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science 2003, 300:1112.
15. Yu Q, Konig R, Pillai S, Chiles K, Kearney M, Palmer S, Richman D, Coffin JM, Landau NR. Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome. Nat Struct Mol Biol 2004, 11:435-442.
16. Harris RS, Liddament MT. Retroviral restriction by APOBEC proteins. Nat Rev Immunol 2004, 4:868-877.
17. Peng G, Greenwell-Wild T, Nares S, Jin W, Lei KJ, Rangel ZG, Munson PJ, Wahl SM. Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression. Blood 2007, 110:393-400.
18. Bourara K, Liegler TJ, Grant RM. Target cell APOBEC3C can induce limited G-to-A mutation in HIV-1. PLoS Pathog 2007, 3:e153.
19. Dang Y, Siew LM, Wang X, Han Y, Lampen R, Zheng YH. Human cytidine deaminase APOBEC3H restricts HIV-1 replication. J Biol Chem 2008, 283:11606-11614.
20. OhAinle M, Kerns JA, Li MM, Malik HS, Emerman M. Antiretroelement activity of APOBEC3H was lost twice in recent human evolution. Cell Host Microbes 2008, 4:249-259.
21. Harari A, Ooms M, Mulder LCF, Simon V. Polymorphisms and splice variants influence the antiretroviral activity of human APOBEC3H. J Virol 2009, 83:295-303.
22. Matsuoka M, Jeang KT. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer 2007, 7:270-280.
23. Derse D, Hill SA, Princlear G, Lloyd P, Heidecker G. The resistance of human T cell leukemia virus type 1 to APOBEC family. Proc Natl Acad Sci U S A 2007, 104:2915-2920.
24. Mahieux R, Suspene R, Delebecque F, Henry M, Schwartz O, Wain-Hobson S, Vartanian J-P. Extensive editing of a small fraction of human T-cell leukemia type 1 genomes by four APOBEC3 cytidine deaminases. J Gen Virol 2005, 86:2489-2494.
25. Fan J, Ma G, Nosaka K, Tanabe J, Satou Y, Koito A, Wain-Hobson S, Vartanian J-P, Matsuoka M. APOBEC3G generates nonsense mutations in human T-cell leukemia type 1 proviral genomes in vivo. J Virol 2010, 84:7278-7287.
26. Turelli P, Mangeat B, Jost S, Vianin S, Trono D. Inhibition of hepatitis B virus replication by APOBEC3G. Science 2004, 303:1829.
27. Turelli P, Jost S, Mangeat B, Trono D. Respose to comment on "inhibition of hepatitis B virus replication by APOBEC3G". Science 2004, 305:1403.
28. Turelli P, Liagre-Quazzola A, Mangeat B, Verp S, Jost S, Trono D. APOBEC3-independent IFN-induced viral clearance in hepatitis B virus transgenic mice. J Virol 2008, 82:6585-6590.
29. Vartanian J-P, Guetard D, Henry M, Wain-Hobson S. Evidence for editing of human papillomavirus DNA by APOBEC3 in benign and precancerous lesions. Science 2008, 320:230-233.
30. Jonsson SR, Hache G, Stenglein MD, Fahrenkrug SC, Andresdottir V, Harris RS. Evolutionarily conserved and non-conserved retrovirus restriction activities of artiodactyl APOBEC3F proteins. Nucleic Acids Res 2006, 34:5683-5694.
31. Mariani R, Chen D, Schrofelbauer B, Navarro F, Konig R, Bollman B, Munk C, Nymark-McMahon H, Landau NR. Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 2003, 114:21-31.
32. Zhang L, Li X, Ma J, Yu L, Jiang J, Cen S. The incorporation of APOBEC3 proteins into murine leukemia viruses. Virology 2008, 378:69-78.
33. Browne EP, Littman DR. Species specific restriction of Apobec3 mediated hypermutation. J Virol 2008, 82:1305-1313.
34. Mikl MC, Watt IN, Lu M, Reik W, Davies SL, Neuberger MS, Rada C. Mice deficient in APOBEC2 and APOBEC3. Mol Cell Biol 2005, 25:7270-7277.
35. Okeoma CM, Lovsin N, Peterlin BM, Ross SR. APOBEC3 inhibits mouse mammary tumor virus replication in vivo. Nature 2007, 445:927-930.
36. Low A, Okeoma CM, Lovsin N, de las Heras M, Taylor TH, Peterlin BM, Ross SR, Fan H. Enhanced replication and pathogenesis of Moloney murine leukemia virus in mice defective in the murine APOBEC3 gene. Virology 2009, 385:455-463.
37. Wiegand HL, Cullen BR. Inhibition of alpharetrovirus replication by a range of human APOBEC3 proteins. J Virol 2007, 81:13694-13699.
38. Bishop KN, Holmes RK, Sheehy AM, Malim MH. APOBEC-mediated editing of viral RNA. Science 2004, 305:645.
39. Ikeda T, Ohsugi T, Kimura T, Matsushita S, Maeda Y, Harada S, Koito A. The anti-retroviral potency of APOBEC1 deaminase from small animal species. Nucleic Acids Res 2008, 36:6859-6871.
40. Petit V, Guetard D, Renard M, Keriel A, Sitbon M, Wain-Hobson S, Vartanian J-P. Murine APOBEC1 is a powerful mutator of retroviral and cellular RNA in vitro and in vivo. J Mol Biol 2009, 385:65-78.
41. Chester A, Somasekaram A, Tzimina M, Jarmuz A, Gisbourne J, O'Keefe R, Scott J, Navaratnam N. The apolipoprotein B mRNA editing complex performs a multifunctional cycle and suppresses nonsense-mediated decay. EMBO J 2003, 22:3971-3982.
42. Fujino T, Navaratnam N, Jarmuz A, Von Haeseler A, Scott J. C→U editing of apolipoprotein B mRNA in marsupials: identification and characterization of APOBEC-1 from the American opossum Monodelphus domestica. Nucleic Acids Res 1999, 27:2662-2671.
43. Tervo H-M, Keppler OT. High natural permissivity of primary rabbit cells for HIV-1, with a virion infectivity defect in macrophages as the final replication barrier. J Virol 2010, 84:12300-12314.
44. Greeve J, Altkemper I, Dieterich JH, Greten H, Windler E. Apolipoprotein B mRNA editing in 12 different mammalian species: hepatic expression is reflected in low concentrations of apoB-containing plasma lipoproteins. J Lipid Res 1993, 34:1367-1383.
45. Ikeda T, Abd El Galil KH, Tokunaga K, Maeda K, Sata T, Sakaguchi N, Heidmann T, Koito A. Intrinsic restriction activity by apolipoprotein B mRNA editing enzyme APOBEC1 against the mobility of autonomous retrotransposons. Nucleic Acids Res 2011, 39:5538-5554.
46. Greeve J, Axelos D, Welker S, Schipper M, Greten H. Distinct promoters induce APOBEC-1 expression in rat liver and intestine. Arterioscler Thromb Vasc Biol 1998, 18:1079-1092.
47. Skuse GR, Cappione AJ, Sowden M, Metheny LJ, Smith HC. The neurofibromatosis type I messenger RNA undergoes base-modification RNA editing. Nucleic Acids Res 1996, 24:478-486.
48. Rosenberg BR, Hamilton CE, Mwangi MM, Dewell S, Papavasiliou FN. Transcriptome-wide sequencing reveals numerous APOBEC1 mRNA-editing targets in transcripts 3' UTRs. Nat Struct Mol Biol 2011, 18:230-238.
49. Renard M, Henry M, Guetard D, Vartanian J-P, Wain-Hobson S. APOBEC1 and APOBEC3 cytidine deaminases as restriction factors for hepadnaviral genomes in non-humans in vivo. J Mol Biol 2010, 400:323-334.
50. Gee P, Ando Y, Kitayama H, Yamamoto SP, Kanemura Y, Ebina H, Kawaguchi Y, Koyanagi Y. APOBEC1-mediated editing and attenuation of HSV-1 DNA implicates an antiviral role in neurons during encephalitis. J Virol 2011, 76:7094-7102.
51. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, et al. Initial sequencing and analysis of the human genome. Nature 2001, 409:860-921.
52. Waterston RH, Lindblad-Toh K, Birney E, Rogers J, Abril JF, Agarwal P, Agarwala R, Ainscough R, Alexandersson M, An P, et al. Initial sequencing and comparative analysis of the mouse genome. Nature 2002, 420:520-562.
53. Bannert N, Kurth R. Retroelements and the human genome: new perspectives on an old relation. Proc Natl Acad Sci U S A 2004, 101:14572-14579.
54. Kazazian HH Jr. Mobile elements: drivers of genome evolution. Science 2004, 303:1626-1632.
55. Jern P, Coffin JM. Effects of retroviruses on host genome function. Annu Rev Genet 2008, 42:709-732.
56. Tristem M. Identification and characterization of novel human endogenous retrovirus families by phylogenetic screening of the human genome mapping project database. J Virol 2000, 74:3715-3730.
57. Nelson PN, Lever AM, Smith S, Pitman R, Murray P, Perera SA, Westwood OM, Hay FC, Ejtehadi HD, Booth JC. Molecular investigations implicate human endogenous retroviruses as mediators of antiretroviral antibodies in autoimmune rheumatic disease. Immunol Invest 1999, 28:277-289.
58. Mayer J. Status of HERV in human cells: expression and coding capacity of human proviruses. Dev Biol 2001, 106:439-441.
59. Lee YN, Bieniasz PD. Reconstitution of an infectious human endogenous retrovirus. PLoS Pathog 2007, 3:e10.
60. Esnault C, Heidmann O, Delebecque F, Dewannieux M, Ribet D, Hance AJ, Heidmann T, Schwartz O. APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses. Nature 2005, 433:430-433.
61. Armitage AE, Katzourakis A, de Oliveira T, Welch JJ, Belshaw R, Bishop KN, Kramer B, McMichael AJ, Rambaut A, Iversen AKN. Conserved footprints of APOBEC3G on hypermutated human immunodeficiency virus type 1 and human endogenous retrovirus HERV-K(HML2) sequences. J Virol 2008, 82:8743-8761.
62. Bogerd HP, Wiegand HL, Doehle BP, Lueders KK, Cullen BR. APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells. Nucleic Acids Res 2006, 34:89-95.
63. Jern P, Stoye JP, Coffin JM. Role of APOBEC3 in genetic diversity among endogenous murine leukemia viruses. PLoS Genet 2007, 3:2014-2022.
64. MacDuff DA, Demorest ZL, Harris RS. AID can restrict L1 retrotransposition suggesting a dual role in innate and adaptive immunity. Nucleic Acids Res 2009, 37:1854-1867.
65. Dutko JA, Schäfer A, Kenny AE, Cullen BR, Curcio MJ. Inhibition of a yeast LTR retrotransposon by human APOBEC3 citidine deaminases. Curr Biol 2005, 15:661-666.
66. Schumacher AJ, Nissley DV, Harris RS. APOBEC3G hupermutates genomic DNA and inhibits Ty1 retrotransposition in yeast. Proc Natl Acad Sci U S A 2005, 102:9854-9859.
67. Kinomoto M, Kanno T, Shimura M, Ishizaka Y, Kojima A, Kurata T, Sata T, Tokunaga K. All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition. Nucleic Acids Res 2007, 35:2955-2964.
68. Niewiadomska AM, Tian C, Tan L, Wang T, Sarkis PTN, Yu X-F. Differential inhibition of long interspersed element 1 by APOBEC3 does not correlate with high-molecular-mass-complex formation or P-body association. J Virol 2007, 81:9577-9583.
69. Bogerd HP, Wiegand HL, Hulme AE, Garcia-Perez JL, O'Shes KS, Moran JV, Cullen BR. Cellular inhibitors of long interspersed element I and Alu retrotransposition. Proc Natl Acad Sci U S A 2006, 103:8780-8785.
70. Stenglein MD, Burns MB, Li M, Lengyel J, Harris RS. APOBEC3 proteins mediate the clearance of foreign DNA from human cells. Nat Struct Mol Biol 2010, 17:222-230.
71. Kano H, Godoy I, Courtney C, Vetter MR, Gerton GL, Ostertag EM, Kazazian HH Jr. L1 retrotransposition occurs mainly in embryogenesis and creates somatic mosaicism. Genes Dev 2009, 23:1303-1312.
72. Yang N, Kazazian HH Jr. L1 retrotransposition is suppressed by endogenously encoded small interfering RNAs in human cultured cells. Nat Struct Mol Biol 2006, 13:763-771.
73. Gerber AP, Keller W. An adenosine deaminase that generates inosine at the wobble position of tRNA. Science 1999, 286:1146-1149.
74. Smith HC. DNA and RNA Modification Enzymes: Structure, Mechanism, Function and Evolution. The APOBEC1 paradigm for mammalian cytidine deaminases that edit DNA and RNA. Chapter 15. In: Grosjean H, ed. Austin: Landes BioScience; 2009, 181-202.
75. Conticello SG, Langlois MA, Yang Z, Neuberger MS. DNA deamination in immunity: AID in the context of its APOBEC relatives. Adv Immunol 2007, 94:37-73.
76. Rubio MAT, Pastar I, Gaston KW, Ragone FL, Janzen CJ, Cross GAM, Papavasiliou FN, Alfonzo JD. An adenosine-inosine tRNA-editing enzyme that can perform C-to-U deamination of DNA. Proc Natl Acad Sci U S A 2007, 104:7821-7826.
77. Betts L, Xiang S, Short SA, Wolfenden R, Carter CW. Cytidine deaminase. The 2.3 Åcrystal structure of an enzyme: transition-state analog complex. J Mol Biol 1994, 235:635-656.
78. Smith HC. Measuring editing activity and identifying cytidine-to-uridine mRNA editing factors in cells and biochemical isolates. Methods Enzymol 2007, 424:389-416.
79. Xie K, Sowden MP, Dance GSC, Torelli AT, Smith HC, Wedekind JE. The structure of a yeast RNA-editing deaminase provides insight into the fold and function of activation-induced deaminase and APOBEC-1. Proc Natl Acad Sci U S A 2004, 101:8114-8119.
80. Conticello SG, Thomas CJF, Petersen-Mahrt SK, Neuberger MS. Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases. Mol Biol Evol 2005, 22:367-377.
81. Münk C, Beck T, Zielonka J, Hotz-Wagenblatt A, Chareza S, Battenberg M, Thielebein J, Cichutek K, Bravo IG, O'Brien SJ, et al. Functions, structure, and read-through alternative splicing of feline APOBEC3 genes. Genome Biol 2008, 9:R48.
82. Severi F, Chicca A, Conticello SG. Analysis of reptilian APOBEC1 suggests that RNA editing may not be its ancestral function. Mol Biol Evol 2011, 28:1125-1129.
83. Zhang J, Webb DM. Rapid evolution of primate antiviral enzyme APOBEC3G. Hum Mol Genet 2004, 13:1785-1791.